Wilmington Investor Network

Tunnel is a developer of cloud-based payment software that facilitates real-time global cross-currency payments without transaction fees. Utilizing distributed ledger technology, Tunnel offers its own payment infrastructure, including application programming interfaces and mobile applications. This innovative approach allows both individuals and companies to conduct transactions securely and efficiently, minimizing costs associated with traditional payment methods while enhancing fraud prevention.

Tunnel is a developer of cloud-based payment software that facilitates real-time global cross-currency payments without transaction fees. Utilizing distributed ledger technology, Tunnel offers its own payment infrastructure, including application programming interfaces and mobile applications. This innovative approach allows both individuals and companies to conduct transactions securely and efficiently, minimizing costs associated with traditional payment methods while enhancing fraud prevention.

Roobrik, Inc. is a company that specializes in providing online assessment and decision tools aimed at assisting older adults, their caregivers, and senior care providers in making informed health and care choices. Founded in 2013 and headquartered in Greensboro, North Carolina, Roobrik's tools focus on simplifying the often complex process of later-life decision-making. They help families navigate critical issues such as driving safety, home safety, and managing dementia, ultimately promoting better health and wellness outcomes while also reducing costs associated with long-term care. By prioritizing informed decision-making, Roobrik empowers users to make choices that enhance their quality of life and care.

Respiratory Motion, Inc. is a medical device company based in Waltham, Massachusetts, that specializes in the development and commercialization of respiratory monitoring devices. Founded in 2011, the company offers the ExSpiron, a point-of-care device designed to non-invasively measure critical respiratory parameters such as minute ventilation, tidal volume, and respiratory rate. With FDA clearance for its continuous monitoring systems, Respiratory Motion provides healthcare professionals with real-time data that enhances patient safety and helps in the early detection of respiratory collapse across various patient populations and clinical settings.

Meta Materials is a platform technology company that specializes in the invention, design, development, and manufacturing of advanced sustainable materials. The company collaborates with original equipment manufacturers (OEMs) across various industries, utilizing its extensive technology platform that includes holography, lithography, and wireless sensing, all driven by software and artificial intelligence. Meta Materials delivers high-performance solutions for applications in consumer electronics, 5G communications, health and wellness, aerospace, automotive, and clean energy. Its notable products include NANOWEB, a transparent conductive film, as well as holoOPTIX, ARfusion, metaAIR, and glucoWISE, which enable global brands to create innovative and impactful products for their customers.

Avhana Health Inc. is a provider of a clinical decision support platform designed to enhance healthcare provider workflows. Founded in 2014 and headquartered in Baltimore, Maryland, the company offers a software application that integrates directly with electronic health records (EHR). This platform simplifies the healthcare process by delivering the latest clinical guidelines, actionable recommendations, and performance metrics. It includes features such as a dashboard for pre-visit planning, patient-specific care recommendations, order suggestions that can be submitted directly to the EHR, and tools for tracking provider activity and performance. By focusing on value-based care enablement, Avhana Health aims to deliver impactful support to healthcare teams, ultimately improving quality of care and reducing healthcare costs.

Validic, Inc. is a technology company specializing in a cloud-based platform that collects and manages mobile health data from various internet-enabled applications and devices. Founded in 2010 and based in Durham, North Carolina, Validic connects healthcare organizations with over 400 clinical and consumer devices, allowing for the integration of patient-recorded data into clinical workflows. Its primary offerings include Validic Solution, which links digital health data to healthcare providers; Validic Connect, which facilitates access to a broader range of clinical and consumer applications; and Validic Mobile, designed for data collection from health apps and in-home devices. The company serves a diverse clientele, including wellness companies, healthcare providers, pharmaceuticals, and health plans, with the goal of enhancing the quality of human life through actionable health data.

Gemmus Pharma Inc. is a biotechnology company based in San Francisco, California, founded in 2007. The company focuses on developing therapeutics for the treatment of influenza and other infectious diseases. Its lead candidates include GP1001, a non-peptidic eicosanoid analog designed for serious influenza infections that may require hospitalization, and GP1681, which aims to alleviate influenza symptoms by reducing the exaggerated cytokine response induced by the virus. GP1001 can be used as a stand-alone treatment or in combination with antiviral drugs such as oseltamivir. Gemmus Pharma has received support from the National Institute of Allergy and Infectious Disease and has plans to file an investigational new drug application with the FDA to advance its influenza treatment initiatives.

Trusted Metrics Inc. is an information security company based in Raleigh, North Carolina, specializing in cloud-based security solutions. The company offers the Elastic SOC®, a comprehensive platform designed for centralized log correlation, intrusion detection, asset management, and network performance management. This multi-tenant platform caters primarily to managed service providers (MSPs) and managed security service providers (MSSPs), allowing them to create white-labeled virtual Security Operations Centers (SOCs) for their clients. Trusted Metrics' managed visibility platform consolidates networking, systems, application, and security event information, enabling organizations to monitor their fixed and dynamic assets, including servers and mobile devices. The platform provides features such as network monitoring, intrusion detection, file integrity monitoring, and customizable alerting and reporting. Trusted Metrics serves a diverse range of industries, including government, education, healthcare, and manufacturing, and is committed to enhancing enterprise visibility and rapid response to security threats. The company was founded in 2010 and became a subsidiary of SolarWinds Worldwide, LLC in 2018.

ABK Biomedical Inc., founded in 2012 and based in Halifax, Canada, develops innovative embolotherapeutic products aimed at treating uterine fibroids, hypervascular tumors, and arteriovenous malformations. The company focuses on enhancing interventional radiology procedures, particularly embolization, by combining clinical market insights with advanced biomaterials. ABK Biomedical's flagship product is a novel radiopaque microsphere designed to improve the targeting of tumor blood vessels and tissue. This technology not only aids in the standardization and optimization of minimally invasive therapies but also facilitates personalized treatment options for patients with complex conditions. Through its commitment to advancing embolotherapy, ABK Biomedical seeks to transform patient care in the field of interventional radiology.

Chaologix, Inc. is a technology company specializing in the development of computing architecture and chip sets. Founded in 2005 and based in Gainesville, Florida, the company focuses on creating processors and architectures that utilize chaotic circuit elements. Their flagship product, the Chaologix system, is applicable in various fields, including desktop and laptop computers, reconfigurable video cards for multimedia and gaming, network routers, chaotic search engine hardware, and advanced medical devices. Additionally, Chaologix technology supports robotics and aerospace applications, including those for NASA and the Department of Defense. The company emphasizes the importance of security in its semiconductor technology, which aims to deter side-channel attacks and enhance data protection, making its solutions relevant in an era of increasing cybersecurity concerns.

Gemmus Pharma Inc. is a biotechnology company based in San Francisco, California, founded in 2007. The company focuses on developing therapeutics for the treatment of influenza and other infectious diseases. Its lead candidates include GP1001, a non-peptidic eicosanoid analog designed for serious influenza infections that may require hospitalization, and GP1681, which aims to alleviate influenza symptoms by reducing the exaggerated cytokine response induced by the virus. GP1001 can be used as a stand-alone treatment or in combination with antiviral drugs such as oseltamivir. Gemmus Pharma has received support from the National Institute of Allergy and Infectious Disease and has plans to file an investigational new drug application with the FDA to advance its influenza treatment initiatives.

OncoHealth is a company that specializes in creating screening devices aimed at the detection and diagnosis of cancer. The primary focus of its devices is the development of protein bio-markers, which are essential for the screening and diagnostic processes related to cervical cancer and other cancers associated with human papillomavirus (HPV). By advancing these technologies, OncoHealth enables medical professionals to effectively monitor, diagnose, and treat cancer, thereby contributing to improved patient outcomes in oncology.

Pique Therapeutics, Inc. is a biopharmaceutical company based in Durham, North Carolina, established in 2005. The company specializes in the development of therapeutic vaccines aimed at treating various forms of cancer, including non-small cell lung cancer, colorectal cancer, head and neck cancer, and pancreatic cancer. Pique Therapeutics is focused on creating innovative solutions that enable physicians to initiate treatment efficiently, positioning itself as a leader in the therapeutic vaccine market.

Basho Technologies, Inc. specializes in NoSQL database solutions designed for large enterprises, including many Fortune 50 companies. The company provides distributed systems that efficiently manage and store unstructured data, enabling the operation of critical web, mobile, and social applications. Its primary offerings include Riak KV, a distributed NoSQL database with multi-cluster replication features, and Riak TS, which is tailored for handling time series data. Additionally, Basho's Riak CS serves as an object storage solution for various cloud environments. The company also supports real-time analytics through integrations with Apache Spark and enhances application performance with Redis and Apache Solr. Basho Technologies caters to multiple industries, such as gaming, healthcare, retail, telecommunications, and technology. Founded in 2002 and headquartered in Bellevue, Washington, Basho was previously known as Basho Strategies Inc. before rebranding in 2008.

Basho Technologies, Inc. specializes in NoSQL database solutions designed for large enterprises, including many Fortune 50 companies. The company provides distributed systems that efficiently manage and store unstructured data, enabling the operation of critical web, mobile, and social applications. Its primary offerings include Riak KV, a distributed NoSQL database with multi-cluster replication features, and Riak TS, which is tailored for handling time series data. Additionally, Basho's Riak CS serves as an object storage solution for various cloud environments. The company also supports real-time analytics through integrations with Apache Spark and enhances application performance with Redis and Apache Solr. Basho Technologies caters to multiple industries, such as gaming, healthcare, retail, telecommunications, and technology. Founded in 2002 and headquartered in Bellevue, Washington, Basho was previously known as Basho Strategies Inc. before rebranding in 2008.

Sensory Analytics, LLC specializes in developing advanced sensory solutions for measuring coating thickness and color in various industries, including aerospace, automotive, coatings, electronics, packaging, medical, and pharmaceuticals. The company offers a range of SpecMetrix systems that provide real-time, non-contact measurement capabilities for both in-process and laboratory applications. These systems deliver precise data on coating thickness, achieving accuracy down to sub-micron levels, which enhances process control and product quality while reducing costs. Sensory Analytics' technology is designed for easy setup and can be used on various substrates, making it suitable for both production environments and quality assurance settings. Founded in 2004 and headquartered in Greensboro, North Carolina, Sensory Analytics continues to innovate in the field of measurement solutions.

Consolidated Asset Recovery Systems, Inc. is a software development company based in Raleigh, North Carolina, specializing in repossession management and marketing solutions for lenders, dealers, and recovery agents. Founded in 2005, the company has created the Internet Based Electronic Asset Management (IBEAM) technology to facilitate the tracking and recovery of assets. Their offerings include repossession management, electronic invoicing, skip tracing, audits, legal demand creation, and automated notifications. With a network of recovery agents across the United States, the company ensures compliance and quality in asset recovery services. Consolidated Asset Recovery Systems has experienced significant growth, positioning itself as a trusted partner for many service providers in the industry. Its commitment to transparency and adaptability allows lenders to manage their underperforming assets efficiently, supported by a comprehensive suite of software and services. As of April 2019, it operates as a subsidiary of Primeritus Financial Services, Inc.

Amulet Pharmaceuticals discovers and develops novel therapeutics using their NORTECHâ„¢ technology to address known liabilities of current therapies serving large unmet markets. Their lead program (AMU-301) treats diabetic gastroparesis an unmet complication of diabetes affecting over 3 million women in the United States.

Wilmington Pharmaceuticals specializes in the development and out-licensing of patient-friendly, fast-dissolving formulations for established medicines. The company focuses on creating simpler and more reliable dosage forms that cater to patient needs. By leveraging a fast-dissolving drug delivery method, Wilmington Pharmaceuticals facilitates rapid product development and commercialization, ensuring that health organizations can access dependable medications efficiently. Their expertise enables them to achieve FDA approval swiftly while minimizing regulatory risks for their licensing partners, ultimately maximizing economic opportunities in the pharmaceutical market.

Affinergy, LLC, based in Durham, North Carolina, specializes in developing products for the purification, concentration, and removal of cells and proteins from tissues and fluids, serving both diagnostic and research applications. The company employs a phage display platform to identify peptides that selectively bind to various targets, including drugs and proteins. Additionally, Affinergy focuses on creating site-specific biological systems using biofriendly linkers that adhere to proteins, drugs, and biomaterial surfaces, thereby enhancing biological outcomes. Their product offerings include implantable devices designed to deliver and retain biologics at surgical sites, particularly in orthopedic and soft tissue repair procedures. Established in 2003, Affinergy has received recognition for its innovative medical device coatings, having been awarded the 2005 Innovation of the Year by Frost & Sullivan. The company's technology has roots in research from Duke University and has been further developed at Becton Dickinson's research center in Research Triangle Park.